Unknown

Dataset Information

0

Dose-response effects of insulin glargine in type 2 diabetes.


ABSTRACT:

Objective

To determine the pharmacokinetic and pharmacodynamic dose-response effects of insulin glargine administered subcutaneously in individuals with type 2 diabetes.

Research design and methods

Twenty obese type 2 diabetic individuals (10 male and 10 female, aged 50 +/- 3 years, with BMI 36 +/- 2 kg/m(2) and A1C 8.3 +/- 0.6%) were studied in this single-center, placebo-controlled, randomized, double-blind study. Five subcutaneous doses of insulin glargine (0, 0.5, 1.0, 1.5, and 2.0 units/kg) were investigated on separate occasions using the 24-h euglycemic clamp technique. RESULTS Glargine duration of action to reduce glucose, nonessential fatty acid (NEFA), and beta-hydroxybutyrate levels was close to or >24 h for all four doses. Increases in glucose flux revealed no discernible peak and were modest with maximal glucose infusion rates of 9.4, 6.6, 5.5, and 2.8 mumol/kg/min for the 2.0, 1.5, 1.0, and 0.5 units/kg doses, respectively. Glargine exhibited a relatively hepatospecific action with greater suppression (P < 0.05) of endogenous glucose production (EGP) compared with little or no increases in glucose disposal.

Conclusion

A single subcutaneous injection of glargine at a dose of >or=0.5 units/kg can acutely reduce glucose, NEFA, and ketone body levels for 24 h in obese insulin-resistant type 2 diabetic individuals. Glargine lowers blood glucose by mainly inhibiting EGP with limited effects on stimulating glucose disposal. Large doses of glargine have minimal effects on glucose flux and retain a relatively hepatospecific action in type 2 diabetes.

SUBMITTER: Wang Z 

PROVIDER: S-EPMC2890358 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3000926 | biostudies-literature
| S-EPMC6486036 | biostudies-literature
| S-EPMC5215447 | biostudies-literature
| S-EPMC5067552 | biostudies-literature
| S-EPMC9314964 | biostudies-literature
| S-EPMC6822975 | biostudies-literature
| S-EPMC4282751 | biostudies-literature
| S-EPMC5990197 | biostudies-other
| S-EPMC5813203 | biostudies-literature
| S-EPMC4737399 | biostudies-literature